Rxcurve
HCPCS J9395 · per 25 MG

Injection, fulvestrant

Products billed under this code include Faslodex, Fulvestrant.

Payment limit per 25 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J9395

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Faslodex AstraZeneca Pharmaceuticals LP 00310-0720-10 20 $100.42
Fulvestrant Hikma Pharmaceuticals USA Inc. 00143-9022-02 20 $100.42
Fulvestrant Sandoz Inc. 00781-3532-12 20 $100.42
Fulvestrant Sandoz Inc. 00781-9055-12 20 $100.42
Fulvestrant Northstar RxLLC 16714-0070-02 20 $100.42
Fulvestrant Accord Healthcare Inc 16729-0436-30 20 $100.42
Fulvestrant Sagent Pharmaceuticals 25021-0462-74 20 $100.42
Fulvestrant Sagent Pharmaceuticals 25021-0471-74 20 $100.42
Fulvestrant Dr. Reddy's Laboratories Inc. 43598-0262-02 20 $100.42
Fulvestrant Dr. Reddy's Laboratories Inc. 43598-0262-23 20 $100.42
Show all 22 products
ProductLabelerNDCUnits / pkgLimit / pkg
Fulvestrant Eugia US LLC 55150-0394-02 20 $100.42
Fulvestrant Alembic Pharmaceuticals Inc. 62332-0650-10 20 $100.42
Fulvestrant FreseniUS Kabi USA, LLC 63323-0715-05 20 $100.42
Fulvestrant BluePoint Laboratories 68001-0484-85 20 $100.42
Fulvestrant BluePoint Laboratories 68001-0522-85 20 $100.42
Fulvestrant BluePoint Laboratories 68001-0626-85 20 $100.42
Fulvestrant Amneal Pharmaceuticals, LLC 70121-1463-02 20 $100.42
Fulvestrant Xiromed, LLC 70700-0284-98 20 $100.42
Fulvestrant Zydus Pharmaceuticals (USA) Inc. 70710-1688-08 20 $100.42
Fulvestrant Athenex Pharmaceutical Division, LLC 70860-0211-74 20 $100.42
Fulvestrant Meitheal Pharmaceuticals Inc. 71288-0555-86 20 $100.42
Fulvestrant Avenacy Inc. 83634-0203-74 20 $100.42

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $5.021 −$0.256 25 MG Injection, fulvestrant v1, posted September 17, 2026
3Q26 $5.277 +$0.339 25 MG Injection, fulvestrant v1, posted September 15, 2026
2Q26 $4.938 −$0.782 25 MG Injection, fulvestrant v1, posted September 15, 2026
1Q26 $5.72 −$1.008 25 MG Injection, fulvestrant v1, posted September 15, 2026
4Q25 $6.728 −$0.249 25 MG Injection, fulvestrant v1, posted September 8, 2026
3Q25 $6.977 +$0.082 25 MG Injection, fulvestrant v1, posted March 10, 2026
2Q25 $6.895 +$0.239 25 MG Injection, fulvestrant v1, posted March 10, 2026
1Q25 $6.656 −$0.85 25 MG Injection, fulvestrant v1, posted December 19, 2025
4Q24 $7.506 −$1.22 25 MG Injection, fulvestrant v1, posted June 11, 2025
3Q24 $8.726 +$0.557 25 MG Injection, fulvestrant v1, posted June 11, 2025
2Q24 $8.169 −$0.276 25 MG Injection, fulvestrant v1, posted March 11, 2025
1Q24 $8.445 +$0.088 25 MG Injection, fulvestrant v1, posted December 19, 2024
4Q23 $8.357 −$1.113 25 MG Injection, fulvestrant v1, posted October 10, 2024
3Q23 $9.47 −$2.616 25 MG Injection, fulvestrant v1, posted June 5, 2024
2Q23 $12.086 −$0.575 25 MG Injection, fulvestrant v1, posted February 23, 2024
1Q23 $12.661 +$1.613 25 MG Injection, fulvestrant v1, posted December 6, 2023
4Q22 $11.048 −$2.969 25 MG Injection, fulvestrant v1, posted June 22, 2023
3Q22 $14.017 +$2.406 25 MG Injection, fulvestrant v1, posted June 9, 2023
2Q22 $11.611 −$4.035 25 MG Injection, fulvestrant v1, posted December 14, 2022
1Q22 $15.646 −$0.333 25 MG Injection, fulvestrant v1, posted June 8, 2022
4Q21 $15.979 −$11.617 25 MG Injection, fulvestrant v1, posted June 2, 2022
3Q21 $27.596 −$17.506 25 MG Injection, fulvestrant v1, posted June 2, 2022
2Q21 $45.102 −$9.663 25 MG Injection, fulvestrant v1, posted March 1, 2022
1Q21 $54.765 – 25 MG Injection, fulvestrant v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files